Miruvor
Sign up
The short answer

What studies of chiropractic found

7papers on chiropractic
1 (few people)person in 1 study testing chiropractic alone
0randomised trials, the strongest kind of study

At a glance, by condition

Long COVID: C Might help, very uncertain

Based on the strongest evidence, studies with no comparison group (very low certainty): 2 findings, all C.

2 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Chiropractic might help some people with long COVID, but research can’t show it yet. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 7 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Chiropractic · Long COVID is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

Long COVID

Symptoms

Smell and taste loss1 study · 1 (few people) person took part in chiropractic Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all); not all results were tested against chance.

Studies with no comparison group1 in the study · less than three months · 16 visits (few people)

Smell and taste loss improved.

The evidence is very uncertain about the effect of chiropractic on smell and taste loss in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 1 study
  1. Long COVID with Parosmia and Exertional Malaise: A case report (2025)

    People in the study
    1 in the study
    Dose
    16 visits
    Outcome
    Reported sense of smell
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Daily functioning1 study · 1 (few people) person took part in chiropractic Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from studies without a control group: no control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design); few people (1 in all).

Studies with no comparison group1 in the study · less than three months · 16 visits (few people)

Daily functioning improved.

The evidence is very uncertain about the effect of chiropractic on daily functioning in long COVID. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
See the 1 study
  1. Long COVID with Parosmia and Exertional Malaise: A case report (2025)

    People in the study
    1 in the study
    Dose
    16 visits
    Outcome
    Exercise tolerance as measured by steps per day
    Effect
    better
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Side effects

No study of this treatment alone reported side effects we could read.

All papers

  1. Long COVID with Parosmia and Exertional Malaise: A case report2025 · case report · 1 in the study
    Summary

    This case report describes a 66-year-old retired military officer with long COVID, including dizziness, exercise intolerance, olfactory deficits and paresthesia. One patient received chiropractic care: Chiropractic Adjustments plus instruction in cervical post-isometric relaxation and oropharyngeal exercises, for less than three months (16 visits). There was no comparison group. Exercise tolerance measured as steps per day progressed from 3,000 steps per day at presentation to 5,000 by the time of this report. Reported sense of smell was almost normal by the end of the study, and episodes of parosmia had become infrequent. The authors state these significant improvements were noted after less than three months of chiropractic care (16 visits). No harms were recorded as events; the authors state possible complications include the side-effects of Paxlovid™, emotional distress related to his father’s illness and subsequent death, and possible reactivation of obstructive sleep apnea. The report is a single case without a comparison group, randomisation or blinding, and the authors do not report a formal conclusion or stated limitations.

  2. Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report.2024 · case report
    Summary

    This case report describes a 41-year-old female with Long-COVID syndrome after contracting COVID-19 in February 2022. She self-medicated with psilocybin and MDMA under a therapist-recommended protocol. The first dosing session, on May 05, 2022, was 1 g of dried golden teacher psilocybin cubensis mushrooms; she reported a 20% improvement in depression, fatigue, joint pains, and headache for 7 days. The second session, 24 days later, was MDMA 125 mg followed 1 h later by 2 g of mushrooms in tea and 1 h later by a second 2 g of mushrooms in tea. After this session the patient reported significant improvement in post-COVID symptoms; headache frequency reduced to approximately once per week from a May 2022 baseline of 5 per week, duration decreased to less than 2–4 h per attack from a typical 8–12 h, and she rated symptom improvement approximately 80%. After another 2 g dose, symptoms abated to 90% relief. She later had an early November relapse, then after 2 g on November 24th reported complete resolution and returned to work 3 days later. Harms included chills and shivering with a sensation of being cold while “coming up” and transient nausea and emesis 40 min after ingestion. No comparison group was studied.

  3. Long COVID Hyposmia/Parosmia and subluxation: A case report2022 · case report · 1 in the study
    Summary

    This case report described a 58-year-old woman with long COVID manifestations including hyposmia, parosmia, brain fog, fatigue, and dry mouth. The setting was not reported. She received ten adjustments over a six-week period, consisting of high velocity low amplitude maneuvers and various minimal force adjustments and reflex therapies. She was also advised to take coenzyme Q-10 and B-complex supplements to compensate for the effect of her statin prescription on coenzyme Q-10 biosynthesis; the statin prescription was background. No comparison group was reported. Outcomes included Weber’s test, brain fog, reverse digit span, sense of smell on the Gupta et al olfactory scale of “0” to “5”, number of sniffs for detecting aromas, a “house on fire” odor, and dry mouth and fatigue. On examination, Weber’s test was positive with lateralization to the right ear. By her tenth visit, Weber’s test was negative, brain fog was gone, reverse digit span was 6 from 5, and she rated her sense of smell between 2 and 3 out of a possible 5 from 1. She was able to detect aromas for as many as 4 “sniffs” in a row, from one to two “sniffs” only. The “house on fire” odor had transformed into a “burnt popcorn” odor. Dry mouth and fatigue were no longer more pronounced than before COVID-19 infection. Harms were not described. No limitations are stated.

  4. Chronic fatigue syndrome.1992 · case report · 1 in the study
    Summary

    This abstract reports a single patient: a 36-yr-old white female who presented with severe fatigue and symptoms consistent with immune deficiency and was later found to be suffering from chronic fatigue syndrome. The paper discusses diagnostic criteria for chronic fatigue syndrome. The treatment described is chiropractic manipulation, given to this patient. No comparison group, randomisation, crossover, setting, duration, follow-up, or blinding is reported. The reported finding is that chiropractic manipulation afforded relief of some symptoms for this patient. No numerical symptom scores, time point, significance test, or analysis population are given. The abstract does not report harms, side effects, or withdrawals for harms; it also does not report the number of patients who started or were analysed. The authors' conclusion is not reported in the abstract beyond the statement of relief of some symptoms. Limitations are not stated in the abstract. The abstract does not report funding or conflicts of interest.

  5. Long COVID with Obstructive Sleep Apnea: A case report2025 · combination: given with other treatments · 1 in the study
    Summary

    This case report describes one 64-year-old corporate consultant with long COVID manifestations. The text reports no study location. The experimental treatment was chiropractic adjustments for vertebral and upper extremity subluxations and cranial faults, administered five times over a four-week period; he was also asked to perform daily oropharyngeal exercises to augment ongoing CPAP therapy, and he was taking Diltiazem™ (a calcium channel blocker), Pradax™ (an anticoagulant), and Zyrtec™ at presentation. There was no comparison group; outcomes are within-patient before/after observations. Blood pressure was 150/98 mm/Hg at presentation and 134/80 mm/Hg on the third visit. Fatigue was rated 2/10 on a scale where 10/10 is most severe, and on the fifth visit he reported 1/10 most days. Before presentation he had not played tennis for several months despite having been accustomed to playing 2-4 times per week; several weeks after the fifth visit he had resumed playing tennis. Sleep and cold sensitivity were also described. The text does not report harms, worsening, or stopping. The authors state no limitations in the available text.

  6. Research progress in the treatment of chronic fatigue syndrome through interventions targeting the hypothalamus-pituitary-adrenal axis.2024 · review
    Summary

    This review examined treatments targeting the hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome (CFS). It included seven RCTs of traditional Chinese medicine (TCM) methods, with sample sizes of 41, 30, 30, 36, 30, 33, and 20 individuals with CFS. No setting was reported. Treatments included pestle needle therapy plus electric acupuncture, Fuyang cupping, Lixujieyu decoction with or without five-element gongdiao music, scalp acupuncture, acupoint acupuncture with a TCM patch, and electric acupuncture; comparisons included electric acupuncture, massage, chiropracty, and cupping, Chinese medicine alone, music alone, no treatment, Vicodin, adenosine triphosphate, and oryzanol, and no therapeutic operation. Treatment duration was not reported. Outcomes were ACTH, CORT and MT levels and circadian measures. Some studies reported ACTH levels significantly higher after treatment in both groups, CORT significantly lower after treatment in both groups, or CORT significantly higher after treatment in both groups; one reported no significant change in control-group serum CORT. The review also states randomized controlled trials have shown beneficial effects of hydrocortisone for some patients but overall evidence is insufficient; long-term treatment is associated with adverse effects including Cushing’s syndrome, osteoporosis, extreme mood changes and seizures. Withdrawals were not reported. The authors state the TCM RCTs have design, allocation concealment, blinding and safety-reporting deficiencies, limiting interpretation.

  7. Advances in Clinical Research on Traditional Chinese Medicine Treatment of Chronic Fatigue Syndrome.2020 · review
    Summary

    This review summarized clinical research on traditional Chinese medicine for chronic fatigue syndrome (CFS), described as CFS or myositis encephalomyelitis (ME). The authors searched PubMed, Web of Science, JAMA Network, CNKI, SinoMed and WanFang Data (2010~2020.3 and 2015~2020.3) and included 77 articles, 20 in English and 57 in Chinese. The reviewed treatments included herbal decoctions and proprietary Chinese medicines, moxibustion, acupuncture, tuina, cupping, and combinations of these. Many summarized studies reported higher total effective rates in observation groups than in control groups; the review did not pool these into a single comparison. Adverse drug reactions were mentioned for an estradiol patch study, without counts. The authors state that exact efficacy is still controversial. They report that diagnostic criteria, treatment methods and efficacy evaluations lack consensus, that repeated experiments were lacking, and that the level of evidence is not good enough.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime